Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Basal insulin peglispro demonstrates preferential hepatic versus peripheral action relative to insulin glargine in healthy subjects.

Henry RR, Mudaliar S, Ciaraldi TP, Armstrong DA, Burke P, Pettus J, Garhyan P, Choi SL, Jacober SJ, Knadler MP, Lam EC, Prince MJ, Bose N, Porksen N, Sinha VP, Linnebjerg H.

Diabetes Care. 2014 Sep;37(9):2609-15. doi: 10.2337/dc14-0210. Epub 2014 Jun 19.

PMID:
24947791
[PubMed - in process]
2.

Modeling and simulations to confirm a controlled hypoglycemic stress test in healthy subjects is not associated with clinically significant QT prolongations.

Tham LS, Fen Zhao CM, Natanegara F, Lowe S, Chen C, Lim CN, Linnebjerg H, Willis BA, Mitchell MI, Wise SD.

Int J Clin Pharmacol Ther. 2014 Sep;52(9):717-25. doi: 10.5414/CP202012.

PMID:
24887333
[PubMed - in process]
3.

Pharmacokinetics, safety, and tolerability of single- and multiple-dose exenatide once weekly in Chinese patients with type 2 diabetes mellitus.

Cui YM, Guo XH, Zhang DM, Tham LS, Tang CC, Mace K, Linnebjerg H.

J Diabetes. 2013 Jun;5(2):127-35. doi: 10.1111/1753-0407.12020.

PMID:
23332026
[PubMed - indexed for MEDLINE]
4.

Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects.

Keller J, Trautmann ME, Haber H, Tham LS, Hunt T, Mace K, Linnebjerg H.

Regul Pept. 2012 Nov 10;179(1-3):77-83. doi: 10.1016/j.regpep.2012.08.005. Epub 2012 Sep 6.

PMID:
22960288
[PubMed - indexed for MEDLINE]
5.

Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial.

Kothare PA, Seger ME, Northrup J, Mace K, Mitchell MI, Linnebjerg H.

BMC Clin Pharmacol. 2012 Mar 19;12:8. doi: 10.1186/1472-6904-12-8.

PMID:
22429273
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Pharmacokinetics and pharmacodynamics of high-dose human regular U-500 insulin versus human regular U-100 insulin in healthy obese subjects.

de la Peña A, Riddle M, Morrow LA, Jiang HH, Linnebjerg H, Scott A, Win KM, Hompesch M, Mace KF, Jacobson JG, Jackson JA.

Diabetes Care. 2011 Dec;34(12):2496-501. doi: 10.2337/dc11-0721. Epub 2011 Oct 12.

PMID:
21994429
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A thorough QT study to evaluate the effects of singledose exenatide 10 μg on cardiac repolarization in healthy subjects.

Linnebjerg H, Seger M, Kothare PA, Hunt T, Wolka AM, Mitchell MI.

Int J Clin Pharmacol Ther. 2011 Oct;49(10):594-604.

PMID:
21961484
[PubMed - indexed for MEDLINE]
8.

Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetes.

Linnebjerg H, Kothare PA, Seger M, Wolka AM, Mitchell MI.

Int J Clin Pharmacol Ther. 2011 Feb;49(2):99-108.

PMID:
21255526
[PubMed - indexed for MEDLINE]
9.

The effect of exenatide on lisinopril pharmacodynamics and pharmacokinetics in patients with hypertension.

Linnebjerg H, Kothare P, Park S, Mace K, Mitchell M.

Int J Clin Pharmacol Ther. 2009 Nov;47(11):651-8.

PMID:
19840529
[PubMed - indexed for MEDLINE]
10.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of exenatide once weekly in Japanese patients with type 2 diabetes.

Iwamoto K, Nasu R, Yamamura A, Kothare PA, Mace K, Wolka AM, Linnebjerg H.

Endocr J. 2009;56(8):951-62. Epub 2009 Aug 25.

PMID:
19706990
[PubMed - indexed for MEDLINE]
Free Article
11.

Pharmacokinetics, pharmacodynamics, tolerability, and safety of exenatide in Japanese patients with type 2 diabetes mellitus.

Kothare PA, Linnebjerg H, Isaka Y, Uenaka K, Yamamura A, Yeo KP, de la Peña A, Teng CH, Mace K, Fineman M, Shigeta H, Sakata Y, Irie S.

J Clin Pharmacol. 2008 Dec;48(12):1389-99. doi: 10.1177/0091270008323750.

PMID:
19047364
[PubMed - indexed for MEDLINE]
12.

Exenatide pharmacokinetics in healthy Chinese subjects.

Zhao X, Cui YM, Zhou Y, Zhang HL, Yeo KP, Linnebjerg H, Tham LS, Kothare P, Teng LL, Mace K, Soon D.

Int J Clin Pharmacol Ther. 2008 Sep;46(9):459-65.

PMID:
18793576
[PubMed - indexed for MEDLINE]
13.

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.

Linnebjerg H, Park S, Kothare PA, Trautmann ME, Mace K, Fineman M, Wilding I, Nauck M, Horowitz M.

Regul Pept. 2008 Nov 29;151(1-3):123-9. doi: 10.1016/j.regpep.2008.07.003. Epub 2008 Jul 16.

PMID:
18675854
[PubMed - indexed for MEDLINE]
14.

Effect of renal impairment on the pharmacokinetics of exenatide.

Linnebjerg H, Kothare PA, Park S, Mace K, Reddy S, Mitchell M, Lins R.

Br J Clin Pharmacol. 2007 Sep;64(3):317-27. Epub 2007 Apr 10.

PMID:
17425627
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Exenatide effects on statin pharmacokinetics and lipid response.

Kothare PA, Linnebjerg H, Skrivanek Z, Reddy S, Mace K, Pena A, Han J, Fineman M, Mitchell M.

Int J Clin Pharmacol Ther. 2007 Feb;45(2):114-20.

PMID:
17323791
[PubMed - indexed for MEDLINE]
16.

Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men.

Soon D, Kothare PA, Linnebjerg H, Park S, Yuen E, Mace KF, Wise SD.

J Clin Pharmacol. 2006 Oct;46(10):1179-87.

PMID:
16988207
[PubMed - indexed for MEDLINE]
17.

Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.

Linnebjerg H, Kothare PA, Skrivanek Z, de la Peña A, Atkins M, Ernest CS, Trautmann ME.

Diabet Med. 2006 Mar;23(3):240-5.

PMID:
16492205
[PubMed - indexed for MEDLINE]
18.

Effect of exenatide on the steady-state pharmacokinetics of digoxin.

Kothare PA, Soon DK, Linnebjerg H, Park S, Chan C, Yeo A, Lim M, Mace KF, Wise SD.

J Clin Pharmacol. 2005 Sep;45(9):1032-7.

PMID:
16100297
[PubMed - indexed for MEDLINE]
19.

The effect of dietary polyunsaturated fatty acids (PUFA) on acute rejection and cardiac allograft blood flow in rats.

Haw MP, Linnebjerg H, Chavali SR, Forse RA.

Transplantation. 1995 Sep 27;60(6):570-7.

PMID:
7570953
[PubMed - indexed for MEDLINE]
20.

Effect of amiloride on arachidonic acid and histamine release from rat mast cells.

Linnebjerg H, Hansen HS, Jensen B.

Agents Actions. 1989 Apr;27(1-2):39-42.

PMID:
2473628
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk